Back to search
FDAFDA · Food and drugs·Recall number D-0750-2026

SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03

Published August 19, 2026 · Recall initiated: July 29, 2026

Summary

FDA records drug Class II recall D-0750-2026, published August 19, 2026 and initiated July 29, 2026. Recalling firm: Apollo Care, LLC; Status: Ongoing; Reported quantity: 9,762 vials.; Lot: Lot: AC-017124, Exp. 8/30/2026; AC-017136, Exp. 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apollo Care, LLC
Distributor
Nationwide within the U.S
Lot
Lot: AC-017124, Exp. 8/30/2026; AC-017136, Exp. 12/31/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03 recalled?

Yes. FDA published recall D-0750-2026 on August 19, 2026. Reported hazard: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail